Trevena Inc (TRVN)

[chemist72]

Finally some news possibly explaining TRVN's HUGE drop.

https://ih.advfn.com/p.php?pid=nmona&article=78436269

Apparently TRVN made misleading public statements in regards to a meeting with the FDA on April 28, 2016.

However, on October 9, 2018, minutes from the FDA's April 28, 2016 meeting with Trevena were released and showed that the FDA:
"did not agree with the proposed dosing in the Phase 3 studies";
"did not agree with the proposed primary endpoint"; and
"did not agree with the proposed non-inferiority (NI) margin for comparing morphine to oliceridine."

Thanks FDA for letting us know this news 2 days before the AD COM meeting.